help button home button Am J Pathol Epitomics, Inc.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ortiz-Zapater, E.
Right arrow Articles by Navarro, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ortiz-Zapater, E.
Right arrow Articles by Navarro, P.
(American Journal of Pathology. 2007;170:1573-1584.)
© 2007 American Society for Investigative Pathology
DOI: 10.2353/ajpath.2007.060850

Tissue Plasminogen Activator Induces Pancreatic Cancer Cell Proliferation by a Non-Catalytic Mechanism That Requires Extracellular Signal-Regulated Kinase 1/2 Activation through Epidermal Growth Factor Receptor and Annexin A2

Elena Ortiz-Zapater*{dagger}, Sandra Peiró*{dagger}, Oriol Roda*{dagger}, Josep M. Corominas{ddagger}, Susana Aguilar*, Coral Ampurdanés*, Francisco X. Real*{dagger} and Pilar Navarro*

From the Unitat de Biologia Cel.lular i Molecular,* Institut Municipal d’Investigació Mèdica, Barcelona; the Departament de Ciències Experimentals i de la Salut,{dagger} Facultat de Ciències de la Salut i de la Vida, Universitat Pompeu Fabra, Barcelona; and the Departament de Patologia,{ddagger} Hospital del Mar, Universitat Autònoma de Barcelona, Barcelona, Spain

Tissue plasminogen activator (tPA) is overexpressed in pancreatic ductal carcinoma and is involved in tumor progression. This effect is probably mediated through the activation of angiogenesis, cell invasion, and cell proliferation. Previous studies support the notion that the effects of tPA on cell invasion require its proteolytic activity. Here, we report the molecular mechanism responsible for the proliferative effects of tPA on pancreatic tumor cells. tPA activates the extracellular signal-regulated kinase 1/2 signaling pathway in a manner that is independent of its catalytic activity. We also show that at least two membrane receptors, epidermal growth factor receptor and annexin A2, which are overexpressed in pancreatic cancer, are involved in the transduction of tPA signaling in pancreatic tumors. This observation suggests the establishment of an amplification loop in tumor cell proliferation. Double immunofluorescence experiments showed co-localization of tPA/epidermal growth factor receptor and tPA/annexin A2 in pancreas cancer cells. These results add novel insights into the non-catalytic functions of tPA in cancer and the molecular mechanisms behind the effects of this protease on cell proliferation, including a role for epidermal growth factor receptor.





This article has been cited by other articles:


Home page
Sci SignalHome page
Y. Shi, E. Mantuano, G. Inoue, W. M. Campana, and S. L. Gonias
Ligand Binding to LRP1 Transactivates Trk Receptors by a Src Family Kinase-Dependent Pathway
Sci. Signal., April 28, 2009; 2(68): ra18 - ra18.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
J. F. A. Swisher, U. Khatri, and G. M. Feldman
Annexin A2 is a soluble mediator of macrophage activation
J. Leukoc. Biol., November 1, 2007; 82(5): 1174 - 1184.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Society for Investigative Pathology.